Introducing the Breather
an innovative low-cost Respiratory muscle training device

Alt Tag

Available to {$companyName!"your facility"} from Columbia Scientific!

Alt Tag

Evidence-Based RMT Treatment

The First Drug-Free inspiratory/Expiratory Respiratory Muscle training (RMT) device

The Breather is a  recommended treatment for multiple diagnoses including Dysphagia, COPD, CHF, Parkinson's Disease, and other Neuromuscular diseases.

Compelling research pointing to significant patient outcomes with this innovative and cost-effective treatment 

Using resistance in both the inspiratory and expiratory phases of the exercise works muscles throughout the whole training session 

Download Research

Cost-Effective for multiple diagnoses 

For under $50 the Breather is an affordable treatment for many diagnoses and conditions  

improve patient outcomes

Studies show RMT strengthens respiratory muscles improving aerobic capacity for ambulation, and completion of  ADLs

decrease length
of stay 

 Studies show RMT is an inexpensive and highly effective method to reduce LOS by 16%. 

saves treatment time & easy to use

RMT only takes a few minutes leaving time for other exercises; patients can continue treatment on their own between sessions and

Alt Tag

Highly Versatile

appropriate modality for most treatment settings and all ages of patients
  • Treat patients ages 4+
  • Effective in group settings
  • Targets diaphragm improving posture and breath control 
  • Reduces fall risk and LOS
  • Can increase cognitive function in elderly
  • Improve cough flow and respiratory airway clearance
  • improve timing of swallow and swallow function
  • Useful for treating patients with asthma, muscular dystrophy, multiple sclerosis, stroke, and other conditions involving respiratory muscle weakness
order now

Bring The Breather to you facility or practice

Respiratory muscle weakness (RMW) is a frequently underdiagnosed, yet highly reversible condition. 

RMW is an under-recognized condition, implications are under-appreciated, and not frequently targeted for therapy across most diagnoses.

contact us for more information